Inventiva publishes lanifibranor results in Biomedicine & Pharmacotherapy
Inventiva (IVA) announced the publication in Biomedicine & Pharmacotherapy, a peer-reviewed, scientific journal, of the results from a ...
Cognition Therapeutics Successfully Passes Pre-defined Futility Analysis of Phase 2 Study of Oral Zervimesine (CT1812) in Geographic Atrophy
Masked Analysis Shows Participants Receiving Oral Zervimesine for at Least 6 Months Experienced Slower Lesion Growth than Participants Receiving ...